HilleVax Statistics
Total Valuation
HilleVax has a market cap or net worth of $90.67 million. The enterprise value is -$103.29 million.
Important Dates
The next estimated earnings date is Monday, November 11, 2024, after market close.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HilleVax has 47.72 million shares outstanding. The number of shares has increased by 22.13% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 47.72M |
| Shares Change (YoY) | +22.13% |
| Shares Change (QoQ) | +1.48% |
| Owned by Insiders (%) | 5.33% |
| Owned by Institutions (%) | 66.26% |
| Float | 23.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.44 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.14, with a Debt / Equity ratio of 0.25.
| Current Ratio | 5.14 |
| Quick Ratio | 4.98 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -49.31 |
Financial Efficiency
Return on equity (ROE) is -73.77% and return on invested capital (ROIC) is -34.23%.
| Return on Equity (ROE) | -73.77% |
| Return on Assets (ROA) | -31.81% |
| Return on Capital (ROIC) | -34.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.74M |
| Employee Count | 90 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.10% in the last 52 weeks. The beta is 0.77, so HilleVax's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -85.10% |
| 50-Day Moving Average | 1.81 |
| 200-Day Moving Average | 9.28 |
| Relative Strength Index (RSI) | 54.98 |
| Average Volume (20 Days) | 116,685 |
Short Selling Information
The latest short interest is 1.26 million, so 2.63% of the outstanding shares have been sold short.
| Short Interest | 1.26M |
| Short Previous Month | 1.82M |
| Short % of Shares Out | 2.63% |
| Short % of Float | 5.27% |
| Short Ratio (days to cover) | 6.51 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -143.40M |
| Pretax Income | -156.27M |
| Net Income | -156.27M |
| EBITDA | -141.71M |
| EBIT | -143.40M |
| Earnings Per Share (EPS) | -$3.39 |
Full Income StatementBalance Sheet
The company has $245.04 million in cash and $51.08 million in debt, giving a net cash position of $193.96 million or $4.06 per share.
| Cash & Cash Equivalents | 245.04M |
| Total Debt | 51.08M |
| Net Cash | 193.96M |
| Net Cash Per Share | $4.06 |
| Equity (Book Value) | 204.93M |
| Book Value Per Share | 4.29 |
| Working Capital | 203.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$111.19 million and capital expenditures -$3.12 million, giving a free cash flow of -$114.32 million.
| Operating Cash Flow | -111.19M |
| Capital Expenditures | -3.12M |
| Free Cash Flow | -114.32M |
| FCF Per Share | -$2.40 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |